REACTHot Line 2Prevention
Prevalence of Silent Atherosclerosis Across Adult Life
Prevalence of silent atherosclerosis across adult life
Presenting authorHenning BundgaardHeart Failure / Cardiomyopathy · Rigshospitalet, Copenhagen, DenmarkHenning Bundgaard is Clinical Professor of Cardiology at the University of Copenhagen and senior consultant at the Department of Cardiology, Rigshospitalet. He is the author or co-author of publications including the 2023 ESC Guidelines for the management of cardiomyopathies and the POET trial on partial oral versus intravenous antibiotic treatment of endocarditis. His ORCID is 0000-0002-0563-7049.
Overview
Pending results on silent atherosclerosis prevalence advise against screening changes; leaves open accurate mapping of subclinical disease across adulthood.
Key result
Silent atherosclerosis prevalence across adult life is being evaluated in a late-breaking trial with results currently pending.
Discussion
Expert reaction lands here the moment REACT reports.
Key Points
- Investigation aims to map the broad prevalence of silent atherosclerosis across adulthood, evaluating asymptomatic arterial plaque buildup.
- Presentation reports late-breaking clinical trial data on atherosclerosis progression across adult life stages, with primary findings pending.
- Clinical trial presentation analyzes vascular disease detection across multiple adult age cohorts to understand subclinical atherosclerosis.
Main Result
Absolute Event Rate: 0% vs 0%